跳至主要内容
临床试验/NCT00004796
NCT00004796已完成2 期

Phase II Study of Lactulose and Circadian Rhythms in Patients With Cirrhosis

National Center for Research Resources (NCRR)0 个研究点目标入组 16 人开始时间: 1994年11月1日最近更新:
适应症
相关药物

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
16

研究概览

简要总结

OBJECTIVES: I. Assess the effect of lactulose on the circadian rhythm of plasma melatonin in patients with subclinical hepatic encephalopathy.

II. Assess the intrasubject variability of circadian melatonin levels and neuropsychological tests.

III. Assess which elements of the neuropsychological test battery show the response to lactulose.

详细描述

PROTOCOL OUTLINE: Patients are alternately assigned to 1 of 2 treatment groups: no therapy for 3 weeks followed by lactulose for 3 weeks versus lactulose for 3 weeks followed by no therapy for 3 weeks.

A dietician advises patients on a 1 g/kg per day protein diet. The lactulose dose is adjusted to result in 2 or 3 loose bowel movements per day.

研究设计

研究类型
Interventional
主要目的
Treatment

入排标准

年龄范围
0 Years 至 64 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • PROTOCOL ENTRY CRITERIA:
  • -Disease Characteristics--
  • Clinical diagnosis of cirrhosis with portal hypertension or portal-systemic shunting
  • -Prior/Concurrent Therapy--
  • No concurrent therapy for hepatic encephalopathy
  • -Patient Characteristics--
  • Age: Under 65
  • Performance status: Not specified
  • Hematopoietic: Not specified
  • Hepatic: See Disease Characteristics
  • Renal: Not specified
  • Other: No alcohol intake within 1 month prior to entry No requirement for beta blockers No requirement for corticosteroids Not in intercontinental travel

排除标准

  • 未提供

研究者

发起方
National Center for Research Resources (NCRR)
申办方类型
Nih

相似试验